PureTech & Qualcomm Collab for ML�driven Vocal Biomarker Tech

Aitechpark12 Jul, 2021Technology

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (?PureTech? or the ?Company?), a clinical-stage biotherapeutics company, is pleased to note that its Founded Entity, Sonde Health (?Sonde?), today announced that it will collaborate with leading chipmaker Qualcomm Technologies, Inc. (?Qualcomm?) to optimize use of Sonde?s vocal biomarker technology on the flagship and high-tier Qualcomm? Snapdragon? 888 and 778G 5G Mobile Platforms to help bring native, machine learning-driven vocal biomarker capabilities to mobile and IoT devices globally. The optimization has the potential to unlock several native health screening and monitoring applications on up to the hundreds of millions of mobile devices that use these Snapdragon mobile platforms.

Recent Profiles

Dr. Aneel Kumar

Dr. Aneel Kumar

View Profile

School Ml — Introducing machine learning in the

School Ml — Introducing Machine Learning In The

View Profile

Ashley Emerson

Ashley Emerson

View Profile

Erungasliva Reddy

Erungasliva Reddy

View Profile

mnm3d

Mnm3d

View Profile

Baji BD

Baji Bd

View Profile

Nhà cái Kuwin

Nhà Cái Kuwin

View Profile

Abigail Adeline

Abigail Adeline

View Profile

bücher slots

Bücher Slots

View Profile